Harvard Bioscience Stock
Price
Target price
€0.49
€0.49
-0.810%
-0.004
-0.810%
-
20.02.26 / Frankfurt
WKN: 578107 / Symbol: HBIO / Name: Harvard / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Harvard Bioscience Stock
The price for the Harvard Bioscience stock decreased slightly today. Compared to yesterday there is a change of -€0.004 (-0.810%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Harvard Bioscience stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Harvard Bioscience in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Harvard Bioscience vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Harvard Bioscience | -0.810% | 6.522% | 1.660% | -57.759% | -10.909% | -82.374% | -86.757% |
| Simulations Plus | 0.980% | 1.980% | -39.412% | -72.162% | -33.117% | -72.162% | -83.520% |
| MicroVision Inc | 5.720% | 14.743% | -1.048% | -54.693% | -2.730% | -72.287% | -95.699% |
| Fonar Corp. New | 0.650% | 0.645% | -1.266% | 9.859% | 0.000% | -4.294% | -1.887% |
Comments
Harvard Bioscience, Inc. (NASDAQ: HBIO) had its price target raised by analysts at Benchmark Co. from $3.00 to $4.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HBIO provided by MarketBeat
News
Harvard University's Investment Manager Loads Up On 3.87M ETHA Shares
According to a SEC filing dated Feb. 13, 2026, Harvard Management Co. Inc. established a new position in the iShares Ethereum Trust ETF (NASDAQ:ETHA), acquiring 3,870,900 shares. The estimated
Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns
In the last few months of 2025, shares of pharmaceutical giant Eli Lilly and Company (NYSE: LLY) went on an undeniable hot streak. From the beginning of August 2025 to the end of the year, the
Billionaire Ken Griffin Just Bought a Quantum Computing Stock That Could Soar by as Much as 101%, According to Wall Street
When it comes to famous investment personalities, names such as Warren Buffett or Jamie Dimon usually get mentioned first. In the world of hedge funds, though, Ken Griffin is the cream of the crop.